StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2013 it was 76.3%, against -35.8% the year before. The highest annual figure on record is 76.3% in fiscal 2013.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2013Dec 31, 201376.3%+112.1
FY2012Dec 31, 2012-35.8%−5.2
FY2011Dec 31, 2011-30.6%+50.9
FY2010Dec 31, 2010-81.5%−48.7
FY2009Dec 31, 2009-32.8%–

More Filana Therapeutics figures

See a number that looks wrong?